Low-dose apixaban as secondary prophylaxis in patients with cancer: is it safe?
Recurrent venous thromboembolism (VTE) and major bleeding are the two major challenges in managing cancer-associated...
Most Read
Extended duration of anticoagulation for cancer-associated thrombosis
Tzu-Fei Wang1, Marc Carrier1* 1Department of Medicine, University of Ottawa at the Ottawa Hospital and The Ottawa...
Can Elevated D-dimer Levels Predict Concomitant and Future Cancer Diagnoses in Patients with Acute Pulmonary Embolism?
The relationship between cancer and thrombosis is a well-established and intricate interplay within the realm of...
Arterial Thromboembolism in Occult Cancer
In 1865, Armand Trousseau famously described unexplained thrombotic events as a first manifestation of occult...
Risk factors and prevention of venous thromboembolism in ambulatory cancer patients requiring chemotherapy
Epidemiology and risk factors Venous thromboembolism (VTE) is a burdensome and frequent complication in patients with...
ICTHIC Magazine is the official online journal of the International Conference on Thrombosis and Hemostasis Issues in Cancer, the major international meeting covering the topic.
ICTHIC Magazine collects contributions from the latest scientific peer-reviewed publications, news, and facts from...
Risk prediction for cancer‐associated thrombosis: A talk with Prof. Pabinger
Professor Pabinger is a hematologist at the University of Vienna, where she studies cancer and thrombosis. During the...
CAT management in older cancer patients
During the ICTHIC webinar, “Challenges in the management of fragile CAT patients (older patient population &...
Anticoagulation of cancer patients with non-valvular atrial fibrillation receiving chemotherapy
Approximately 4% of cancer patients have non-valvular atrial fibrillation (NVAF) and require anticoagulation for...
Rapping about new anticoagulants for CAT at ICTHIC 2018
Rapping about new anticoagulants for CAT at ICTHIC 2018 Cancer patients are four or five times as likely to develop...